Back to Newsroom
Back to Newsroom

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Clariant AG To Contact Him Directly To Discuss Their Options

Tuesday, 02 August 2022 05:44 PM

Faruqi & Faruqi, LLP

Topic:
Lawsuits

NEW YORK, NY / ACCESSWIRE / August 2, 2022 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Clariant AG ADR ("Clariant AG" or the "Company") (OTC PINK:CLZNY).

If you suffered losses exceeding $50,000 investing in Clariant AG stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/CLZNY.

Faruqi & Faruqi, LLP, Tuesday, August 2, 2022, Press release picture

There is no cost or obligation to you.

Faruqi & Faruqi, LLP, Tuesday, August 2, 2022, Press release picture

Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California and Georgia.

On February 14, 2022, Swiss chemical maker, Clariant AG, disclosed that it will delay issuing Q4 2021 and full year 2021 financial results due an ongoing internal investigation into potential accounting fraud.

Clariant AG is investigating internal whistleblower complaints that the company has known about since September 2021, pertaining to booking issues aimed at boosting results to meet targets.

On this news, shares of Clariant AG ADR shares fell more than 14% in intraday trading on February 14, 2022.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

SOURCE: Faruqi & Faruqi, LLP

Topic:
Lawsuits
Back to newsroom
Back to Newsroom
Share by: